Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)
NCT ID: NCT01635413
Last Updated: 2021-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
444 participants
INTERVENTIONAL
2012-09-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GET FIT Prostate: A Randomized Controlled Exercise Trial
NCT03741335
Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors
NCT00246818
Exercise Intervention for Cancer Survivors and Caregivers
NCT01883635
Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer
NCT01186367
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA
NCT05747209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Compare the relative efficacy of tai chi and strength training to prevent falls in female cancer survivors.
II. Determine the mechanism by which tai chi and strength training each reduces the risk of falls.
III. Determine how well the benefits of each intervention persist after structured training stops.
SECONDARY OBJECTIVE:
I. Evaluate the effect of the intervention on physical functioning.
OUTLINE: Patients are randomized to 1 of 3 treatment arms.
ARM I: Patients attend strength training classes for 1 hour 2 days per week.
ARM II: Patients attend tai chi classes for 1 hour 2 days per week.
ARM III: Patients attend supervised stretching and relaxation classes for 1 hour 2 days per week.
In all arms, treatment continues for 6 months.
After completion of study treatment, patients are followed up for 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (strength training)
Patients attend strength training classes for 1 hour 2 days per week.
Exercise Intervention
Undergo strength training classes
Questionnaire Administration
Ancillary studies
Arm II (tai chi)
Patients attend tai chi classes for 1 hour 2 days per week.
Exercise Intervention
Undergo tai chi classes
Questionnaire Administration
Ancillary studies
Arm III (control)
Patients attend supervised stretching and relaxation classes for 1 hour 2 days per week.
Exercise Intervention
Undergo stretching and relaxation classes
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Intervention
Undergo strength training classes
Exercise Intervention
Undergo tai chi classes
Exercise Intervention
Undergo stretching and relaxation classes
Questionnaire Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed chemotherapy \> 3 months prior to enrollment and no concurrent adjuvant therapy other than hormone manipulation therapy for breast cancer (confirmed by patient self-report on the Health History Questionnaire; if patient is unable to confirm whether or not she completed chemotherapy 3 months prior to enrollment, we will send a letter to her physician to confirm eligibility on this criterion)
* Postmenopausal (confirmed by self-report on the Health History Questionnaire; menopausal status could also be confirmed by a recent \[\< 6 months from enrollment\] laboratory report documenting serum follicle-stimulating hormone \[FSH\] \> 30 mIU/ml and/or serum estradiol \< 30 pg/ml)
* Currently underactive (\< 60 minutes of moderate intensity exercise per week in the last month) (confirmed by self-report on the Health History Questionnaire)
Exclusion Criteria
* A medical condition, movement or neurological disorder, or medication use that contraindicates participation in moderate intensity exercise (confirmed by self-report on the Health History Questionnaire, and by physician clearance; if in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible)
50 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
OHSU Knight Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kerri Winters
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerri Winters-Stone
Role: PRINCIPAL_INVESTIGATOR
OHSU Knight Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OHSU Knight Cancer Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sitemba J, Crisafio M, Li F, Eckstrom E, Winters-Stone KM. Evaluating recruitment, retention, and adherence patterns in the GET FIT fall prevention exercise trial in older, postmenopausal cancer survivors. Support Care Cancer. 2025 Jul 28;33(8):727. doi: 10.1007/s00520-025-09767-1.
Winters-Stone KM, Stoyles SA, Dieckmann NF, Eckstrom E, Luoh SW, Horak FB, Roeland EJ, Li F. Can strength training or tai ji quan training reduce frailty in postmenopausal women treated with chemotherapy? A secondary data analysis of the GET FIT trial. J Cancer Surviv. 2024 Aug;18(4):1179-1189. doi: 10.1007/s11764-024-01592-5. Epub 2024 Apr 20.
Winters-Stone KM, Roeland EJ, Li F, Eckstrom E, Horak F, Dieckmann NF, Stoyles SA, Luoh SW. Reply to Y.-T. Hu et al. J Clin Oncol. 2023 Sep 10;41(26):4316-4317. doi: 10.1200/JCO.23.01034. Epub 2023 Jun 28. No abstract available.
Winters-Stone KM, Horak F, Dieckmann NF, Luoh SW, Eckstrom E, Stoyles SA, Roeland EJ, Li F. GET FIT: A Randomized Clinical Trial of Tai Ji Quan Versus Strength Training for Fall Prevention After Chemotherapy in Older, Postmenopausal Women Cancer Survivors. J Clin Oncol. 2023 Jun 20;41(18):3384-3396. doi: 10.1200/JCO.22.01519. Epub 2023 Mar 8.
McGinnis GJ, Holden S, Yu B, Ransom C, Guidarelli C, De B, Diao K, Boyce D, Thomas CR Jr, Winters-Stone K, Raber J. Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention. Oncotarget. 2022 Nov 17;13:1259-1270. doi: 10.18632/oncotarget.28310.
Winters-Stone KM, Li F, Horak F, Luoh SW, Bennett JA, Nail L, Dieckmann N. Comparison of tai chi vs. strength training for fall prevention among female cancer survivors: study protocol for the GET FIT trial. BMC Cancer. 2012 Dec 5;12:577. doi: 10.1186/1471-2407-12-577.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2012-01141
Identifier Type: REGISTRY
Identifier Source: secondary_id
MR00045870
Identifier Type: -
Identifier Source: secondary_id
CPC-12080-LX
Identifier Type: -
Identifier Source: secondary_id
IRB00008560
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00008560
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.